New Insights into Cellular Stress Response: A Potential Target for Heart Failure Treatment
Discover how the enzyme NNT influences heart failure with preserved ejection fraction and opens new possibilities for targeted therapies. Research highlights the potential of inhibiting NNT to treat this complex condition.
Researchers from the German Center for Cardiovascular Research (DZHK) have uncovered a significant molecule involved in a form of heart failure known as HFpEF (heart failure with preserved ejection fraction), which has historically proved resistant to targeted therapies. HFpEF occurs when the heart pumps normally but still fails to supply sufficient blood to meet the body's needs, a condition increasingly prevalent among individuals with obesity and hypertension.
The study, led by Professor Johannes Backs at Heidelberg University Hospital, focuses on the enzyme nicotinamide nucleotide transhydrogenase (NNT), located in the mitochondria—the energy-producing structures within cells. NNT plays a crucial role in balancing energy production and protecting cells from oxidative stress caused by free radicals. The research reveals that NNT's activity influences the development of HFpEF by mediating the heart's response to metabolic stresses.
By utilizing a mouse model, scientists found that animals deficient in functional NNT exhibited remarkable resistance to developing HFpEF, despite displaying typical risk factors such as obesity, high blood pressure, and glucose intolerance. This provides compelling evidence that NNT is central to the pathological remodeling of the heart muscle involved in HFpEF. Moreover, the study identified the growth factor FGF1, which is activated by NNT, as being associated with the stiffening of the heart muscle—a key feature of HFpEF.
These findings open promising avenues for developing targeted treatments aimed at inhibiting NNT. Such therapies could potentially mitigate or halt the progression of this complex and often challenging form of heart failure. The research underscores the importance of understanding individual cellular responses to metabolic stress and highlights NNT as a potential therapeutic target for improving heart failure outcomes.
This groundbreaking study has been published in Circulation Research and offers hope for more effective management strategies for patients suffering from HFpEF, which currently lacks specific targeted therapies.
Source: https://medicalxpress.com/news/2025-07-cellular-stress-response-potential-therapeutic.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Declining Vaccination Rates and Their Role in Accelerating Antibiotic Resistance
Lower vaccination rates are fueling the rise of antibiotic resistance by increasing preventable infections and antibiotic use. Boosting vaccination coverage is key to curbing this global health threat.
Early Detection of Alzheimer's Disease Using Brain and Blood Biomarkers in Middle Age
New research shows that Alzheimer's disease biomarkers can be detected in the brain and blood during middle age, paving the way for earlier diagnosis and intervention strategies. This breakthrough could transform how the disease is screened and managed in the future.
Compassionate Decision-Making Strategies for Families of Critically Ill Children
Discover compassionate decision-making strategies that help families and healthcare providers navigate critical choices for seriously ill children, reducing emotional distress and fostering honesty.
Modifiable Risk Factors Elevate Health Risks for Dementia Caregivers
Many dementia caregivers face modifiable health risk factors like obesity and hypertension, increasing their own risk of developing dementia. Addressing these risks is vital for caregiver health and dementia prevention.